- Home
- SLNO vs PDO Comparison
SLNO vs PDO Comparison
Compare SLNO & PDO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
N/A
Current Price
$31.38
Company Overview
Basic Information| Metric | SLNO | PDO |
|---|---|---|
| Founded | 1999 | 2020 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Electromedical & Electrotherapeutic Apparatus | Trusts Except Educational Religious and Charitable |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.3B | 1.9B |
| IPO Year | 2014 | N/A |
Fundamental Metrics
Financial Performance| Metric | SLNO | PDO |
|---|---|---|
| Price | $31.38 | $12.62 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 11 | 0 |
| Target Price | ★ $105.27 | N/A |
| AVG Volume (30 Days) | ★ 1.4M | 868.3K |
| Earning Date | 05-06-2026 | 01-01-0001 |
| Dividend Yield | N/A | ★ 11.80% |
| EPS Growth | ★ 108.90 | N/A |
| EPS | ★ 0.39 | N/A |
| Revenue | ★ $1,450,788.00 | N/A |
| Revenue This Year | $150.65 | N/A |
| Revenue Next Year | $56.10 | N/A |
| P/E Ratio | $84.82 | ★ N/A |
| Revenue Growth | ★ 138.82 | N/A |
| 52 Week Low | $32.15 | $12.48 |
| 52 Week High | $89.12 | $14.25 |
Technical Indicators
Market Signals| Indicator | SLNO | PDO |
|---|---|---|
| Relative Strength Index (RSI) | 29.14 | 25.87 |
| Support Level | N/A | N/A |
| Resistance Level | $41.48 | $14.13 |
| Average True Range (ATR) | 1.83 | 0.20 |
| MACD | -0.49 | -0.09 |
| Stochastic Oscillator | 9.74 | 10.76 |
Price Performance
Historical Comparison SLNO
PDO
About SLNO Soleno Therapeutics Inc.
Soleno Therapeutics Inc is a biopharmaceutical company developing novel therapeutics for the treatment of rare diseases. Its product candidate DCCR (Diazoxide Choline) Extended-Release tablets, is a proprietary extended-release formulation of a crystalline salt of diazoxide. DCCR has demonstrated the ability to activate the KATP channel in the brain, pancreas, and fat tissue.
About PDO PIMCO Dynamic Income Opportunities Fund of Beneficial Interest
PIMCO Dynamic Income Opportunities Fund is a closed-end management investment company. The fund's primary investment objective is to generate a level of income that is higher than that generated by high-quality, intermediate-term U.S. debt securities.